Mark Udell - Jan 1, 2018 Form 4 Insider Report for Cure Pharmaceutical Holding Corp. (AVRW)

Signature
/s/ Mark Udell
Stock symbol
AVRW
Transactions as of
Jan 1, 2018
Transactions value $
$0
Form type
4
Date filed
5/27/2021, 07:40 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVRW Stock Option Award $0 +150K $0.00 150K Jan 1, 2018 Common Stock 150K $0.74 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option becomes exercisable on the basis determined by the equity incentive plan with 6.25% of the option vesting on the first quarter anniversary of vesting start date. For each additional quarter of the participant's service the option will continue to vest until the vested ratio is 100%. This late filing is due to an inadvertent administrative error and not any error of the reporting person.